Benitz William E
Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Eur J Pediatr. 2025 May 27;184(6):363. doi: 10.1007/s00431-025-06192-8.
The recent meta-analysis by Matsushita et al on "Heterogeneity in treatment response for patent ductus arteriosus" confirms prior results showing that medical treatment of PDA does not reduce but increases mortality. The discussion implies that there is heterogeneity in effects of treatment on mortality, but this is not consistent with the data. The implication of their analysis is that early medical treatment of PDA in preterm infants should be abandoned, as recommended in the recent Clinical Report from the American Academy of Pediatrics.
松下等人最近关于“动脉导管未闭治疗反应的异质性”的荟萃分析证实了先前的结果,即动脉导管未闭的药物治疗不会降低死亡率,反而会增加死亡率。该讨论暗示治疗对死亡率的影响存在异质性,但这与数据不符。他们分析的含义是,应放弃对早产儿动脉导管未闭的早期药物治疗,正如美国儿科学会最近的临床报告中所建议的那样。